SUBSCRIBE

Breaking News on Contract Research, Manufacturing & Clinical Trials

Hot Topics > Globalisation

News in brief

Exela expands North Carolina facility

09-Jan-2013

Exela Pharma Sciences will invest $8.5million in its research and manufacturing plant in North Carolina. The venture, to be spread over the next three years, will provide 38 new jobs almost doubling its present workforce. 

The 20,000sqft cGMP site in Lenoir, Caldwell County offers R&D and manufacturing of injectable, ophthalmic and inhalation solutions both in-house and on a contract basis.

The expansion is supported by a $189,000 grant from the One North Carolina Fund. The local economy has been boosted by this fund, backed by State governor Bev Perdue, and the area has cultivated a high-end business climate attracting a plethora of biotech companies.

According to the North Carolina Department of Commerce, state investment of $1.2billion in the last ten years has led to more than 538 bioscience companies having operations in the area, employing over 58,000 people.

The world’s first state-supported biotechnology centre is based there, as are many of the Big Pharma companies, including GlaxoSmithKline, Novartis and Pfizer.

Key Industry Events

 

Access all events listing

Our events, Events from partners...